| Sign In to gain access to subscriptions and/or personal tools. |
Transcatheter Implantation of Intravascular Stents for Postoperative Residual Stenosis of Peripheral Pulmonary Artery StenosisDepartment of Pediatrics, Taipei Veterans General Hospital, Taipei, R.O.C., National Yang-Ming University
Department of Pediatrics, Taipei Veterans General Hospital, Taipei, R.O.C.
Taichung Veterans General Hospital, Taichung, R.O.C.
Taichung Veterans General Hospital, Taichung, R.O.C.
Department of Pediatrics, Taipei Veterans General Hospital, Taipei, R.O.C.
Department of Pediatrics, Taipei Veterans General Hospital, Taipei, R.O.C.
Department of Pediatrics, Taipei Veterans General Hospital, Taipei, R.O.C.
Department of Surgery, Taipei Veterans General Hospital, Taipei, R.O.C.
Department of Pediatrics, Taipei Veterans General Hospital, Taipei, R.O.C.
This is a prospective study of transcatheter implantation of 11 intravascular stents in 7 patients with status/post (S/P) surgical correction of major cardiovascular lesions. The safety and efficacy of balloon-expandable stents for treatment of peripheral pulmonary artery stenosis (PPAS) is evaluated and analyzed. Although the transcatheter implantation of intravascular stents has been reported as a possible treatment for stenotic peripheral pulmonary arteries, the results of intermediate follow-up studies on patients with S/P surgical correction for residual PPAS need to be evaluated. From June 1998 to December 2001, a total of 15 patients with PPAS having S/P surgery for major cardiovascular lesions were enrolled in this study. Eight of them had redo surgery after complete evaluation and the other 7 patients who might be at higher risk of mortality or morbidity from redo surgery, underwent transcatheter implantation of stents to dilate significant PPAS. Tetralogy of Fallot, S/P total correction, was done in 6 and transposition of great vessels, S/P Jatene operation, was done in 1. There were 10 stents (P 308 Palmaz stent x8 and IntrastentTM x2) implantation for 10 sites of the stenotic PPAS in these 7 patients, who were aged from 3.6 to 17.3 (10.1 ±5.6) years and had body weights ranging from 17 to 72.5 (37.1 ±23.0) kg. The narrowest diameter of the stenotic peripheral pulmonary arteries and pressure gradients across the stenosis were measured before and after implantation of stents. A follow-up catheterization and pulmonary angiography was performed 1 year later to evaluate the intermediate efficacy of stents implantation. All the stenotic peripheral pulmonary arteries of these 7 patients had a significant reduction of pressure gradients immediately after the procedure. The narrowest mean diameter of pulmonary arteries increased from 6.7 ±3.4 to 11.3 ±3.0 mm (p<0.001), and the mean pressure gradient dropped from 31 ±9.9 to 11.4 ±4.6 mm Hg (p<0.001). The follow-up catheterization 1 year later revealed a persistent effect in all but 1 patient. Only a young male presented with a recurrent stenosis with a pressure gradient of
Angiology, Vol. 55, No. 5,
493-498 (2004) |
|||
20 mm Hg, which was relieved by redilation with implantation of another stent. There was no immediate or intermediate complication. Transcatheter stent implantation for treatment of a significant residual PPAS after surgical correction of complicated congenital heart disease is a safe and effective procedure. Since children are growing with age, a long-term follow-up study to evaluate the effects and possible problems of stent implantation is mandatory.